Viewing StudyNCT00422799



Ignite Creation Date: 2024-05-05 @ 5:17 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00422799
Status: COMPLETED
Last Update Posted: 2020-10-27
First Post: 2007-01-12

Brief Title: Combination Bortezomib and Rituximab in Patients With Waldenstroms Macroglobulinemia WM
Sponsor:
Organization: Dana-Farber Cancer Institute